About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Senescent Immunity in Elders and Vaccine Responses (SILVER)

NCT04077424·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vanderbilt University Medical Center

Age

65–125

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Age 65 years and over
Independent Living (including Assisted Living)

You may not be if

Unable to understand the consent or the study.
Allergic to any vaccine components, excluding eggs.
History of Guillain-Barre.
Residing in a long -term care facility such as a nursing home.

The record

StatusCompleted

PhasePhase 4

Taking part10

StartedOct 2019

UpdatedJul 12, 2022

Conditions

Where1

Vanderbilt University Medical Center
Nashville, Tennessee, United States

Clareo Health | Senescent Immunity in Elders and Vaccine Responses (SILVER)